It was a Tuesday morning in early March when I first met Sheila Kessler — not in a conference room or over a scheduled call, but standing behind her at a Shell station on South Boulevard in Charlotte, North Carolina. She was on the phone, voice barely above a whisper but carrying enough tension to cut through the noise of idling engines. “I can’t keep paying $340 a month just to stay healthy,” she said to whoever was on the other end. “Something has to give.”
I paid for my coffee, hesitated at the door, and then turned back. I handed her my card, explained what I do, and asked if she’d be willing to share her story. She looked at the card for a long moment. “Sure,” she said finally. “Maybe somebody else can avoid what I’m going through.”
A Career in Numbers, A Crisis She Didn’t See Coming
When I sat down with Sheila Kessler a week later at a diner in Charlotte’s NoDa neighborhood, she arrived with a manila folder thick with insurance statements, pharmacy receipts, and collection notices. At 61, she has spent nearly three decades as a senior accountant — someone who understands precisely how money moves. Which made what happened to her in February 2026 all the more disorienting.
Her employer, a mid-size logistics firm, switched insurance carriers at the start of the year. The new plan restructured its drug formulary, bumping two of Sheila’s three prescription medications to higher cost-sharing tiers. Her monthly out-of-pocket jumped from $45 to $340 — a difference of $295 every single month on a gross income she described as “just over $31,000 a year.”
Sheila manages blood pressure medication, a thyroid prescription, and a brand-name medication for a chronic condition she’s handled since her late forties. Under the old plan, two of the three were covered as generics at the lowest formulary tier. The new plan classified the brand-name as non-preferred and re-tiered one of the generics as well. “I called the pharmacy and they read me the new prices and I just stood there,” Sheila told me. “I said, ‘Can you read that again?’ Because I thought I’d misheard.”
The Second Crisis Running Underneath
The prescription shock wasn’t landing in isolation. Sheila is engaged — her partner, Marcus, is enrolled in a two-year nursing program and not currently working. Their combined household income rests almost entirely on Sheila’s paycheck. And simultaneously, a $4,800 medical debt from a 2022 emergency room visit had recently been transferred to a collections agency and escalated to a formal garnishment proceeding.
In January 2026, Sheila received a court garnishment notice. Under North Carolina law, creditors who obtain a judgment can garnish wages — typically up to 10 percent of gross earnings. On her salary, that translated to roughly $248 per month being withheld before she ever saw it. Between the garnishment and the new prescription costs, she was absorbing nearly $590 in unexpected monthly outflows that hadn’t existed when the year began.
Sheila told me she delayed filling one of her prescriptions for three weeks in February, rationing the remaining pills she had on hand. She hadn’t told Marcus the full extent of it. “He’s got enough pressure with school,” she said. “I didn’t want him to feel like he needed to drop out just because I was struggling.” That combination — the financial pressure and the instinct to protect someone she loved from knowing — is something I’ve heard in other interviews with people in similar situations. The isolation it creates tends to make the problem harder to solve.
What Changed — and How She Found It
The turning point came through a coworker who offhandedly mentioned something called patient assistance programs — direct pharmaceutical manufacturer initiatives that provide medications at little or no cost to qualifying patients. Sheila had never heard of them. That night, she searched online and landed on NeedyMeds.org, a nonprofit database that organizes patient assistance programs by drug name and manufacturer, free to search.
She applied to two manufacturer programs within the week. One covered her brand-name medication entirely — $0 per month — after she submitted proof of income and her insurance documentation. The second reduced her other out-of-pocket cost to $12 a month. From $340 down to $12. She described sitting at her kitchen table when the confirmation letters came in. “I just cried,” she told me. “Not because it fixed everything. But because it was the first time in two months something had actually worked.”
Separately, a community health navigator at a Charlotte-area nonprofit told Sheila something else she hadn’t known: her employer’s mid-year insurance change likely qualified as a Special Enrollment Period triggering event under ACA rules. That meant she had a window — typically 60 days from the qualifying event — to shop for a marketplace plan that might carry a more favorable formulary for her specific medications. According to Healthcare.gov, a significant change in employer-sponsored coverage, including cost-sharing increases, can qualify a person for Special Enrollment Period access outside the standard November-January Open Enrollment window.
The Numbers Today — and What Remains Unresolved
When I followed up with Sheila in late March 2026, her prescription costs had dropped to $12 a month. The garnishment was still technically active, but she had submitted a voluntary repayment proposal through the nonprofit credit counseling agency — a structured monthly payment that the collections firm had agreed to review, pausing automatic withholding in the meantime. It wasn’t a resolution. It was a pause, and she knew the difference.
She had not yet finalized a marketplace plan. The ACA options available in the Charlotte area required more careful comparison than she’d had time for during the worst weeks of February. Her employer’s HR department had extended an internal review window through mid-April, and she planned to make a final decision before that closed.
There is a particular kind of financial stress that comes from understanding exactly what the numbers say and still not seeing a way through them. Sheila understood the math better than most people ever would. The gap between financial literacy and financial access is real, and it had found her at 61, with retirement still approximately four years away and a partner still building toward a first career.
What Sheila’s Story Reveals About a Broader Access Problem
Sheila’s situation is not unusual in its structure. Millions of Americans with employer-sponsored insurance face mid-year plan changes that materially shift their cost exposure — and a significant portion don’t know those changes can trigger Special Enrollment Period rights on the ACA marketplace. Prescription cost-sharing in particular has increased as more employer plans restructure formulary tiers to shift costs onto patients.
Patient assistance programs, meanwhile, remain dramatically underused. NeedyMeds.org maintains a database of more than 1,000 programs from major manufacturers, yet awareness of these resources stays low even among healthcare workers and social service providers. Sheila — a trained accountant who manages numbers professionally — had never encountered them. That gap is not a personal failure. It reflects how poorly these programs are publicized relative to the need they could meet.
When I last spoke with Sheila by phone in early April 2026, she was cautious but no longer in crisis mode. The debt wasn’t gone. Marcus still had over a year of nursing school remaining. And she was 61 — closer to Medicare eligibility than she’d ever been, but not there yet, still navigating a system built for people whose situations are tidier than hers. “I feel like I’m holding a lot of plates,” she told me. “But at least I know where the plates are now.”
That, she said, was the real shift — not a rescue, but visibility. Knowing what existed, where to look, and that she didn’t have to absorb every cost the system handed her by default. For anyone reading this who recognizes pieces of her story in their own situation, that visibility is where it has to start.
(function(){var w=document.getElementById(‘pvv-scenario-s1775663693471huem’);if(!w)return;var btns=w.querySelectorAll(‘button[data-choice]’);btns.forEach(function(b){b.addEventListener(‘click’,function(){if(w.dataset.revealed)return;w.dataset.revealed=’1′;btns.forEach(function(x){x.style.opacity=x===b?’1′:’0.45′;x.style.cursor=’default’;x.style.transform=’none’});var o=document.getElementById(‘s1775663693471huem-out-‘+b.dataset.choice);if(o){o.style.display=’block’}});b.addEventListener(‘mouseenter’,function(){if(!w.dataset.revealed){b.style.borderColor=’#38bdf8′;b.style.transform=’translateX(4px)’}});b.addEventListener(‘mouseleave’,function(){if(!w.dataset.revealed){b.style.borderColor=’#334155′;b.style.transform=’none’}})})})();
.pvv-faq-section details summary::-webkit-details-marker{display:none}.pvv-faq-section details summary::marker{display:none;content:””}.pvv-faq-section details[open] summary .pvv-faq-arrow{transform:rotate(90deg)}
Leave a Reply